AMPH 8-K 2026-08-06

Amphastar Pharmaceuticals, Inc. (AMPH) 8-K dated 2026-08-06 — accession 0001297184-26-000045. This URL is the filing, not the AMPH hub.

Amphastar Pharmaceuticals, Inc. (AMPH) is a drug manufacturers - specialty & generic company listed on NASDAQ.

Amphastar Pharmaceuticals, Inc. filed a 8-K on 2026-08-06. Accession 0001297184-26-000045.

Cached items: 2.02, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported AMPH revenue for 2025-12-31 was $719.9M. Net income was $98.1M. Revenue was down 1.7% from 2024-12-31 to 2025-12-31. AMPH currently screens at market cap $880.1M.

Not investment advice. The AMPH SEC hub lists recent forms. The stock page is the research view.